Both in Pharmaceuticals
Tyra Biosciences vs Mineralys Therapeutics
Over the past year TYRA returned +38.5% and MLYS returned −59.2%; their daily moves had a correlation of 0.20.
TYRA +38.5% MLYS −59.2%Growth of $1, one year, split-adjusted
| Metric | TYRA | MLYS |
|---|---|---|
| Price | $21.37 | $15.99 |
| Market cap | $1.47B | $1.41B |
| Today | +0.19% | +2.83% |
| 1 month | +2.1% | −31.4% |
| 6 months | −37.0% | −45.4% |
| Year to date | −18.7% | −55.9% |
| 1 year | +34.9% | −60.9% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $353.9M | $563.8M |
| Dividend yield | — | — |
| Volatility (60d) | 74.6% | 72.4% |
| Short % of float | 26.5% | 11.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).